-
1
-
-
8244225821
-
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients
-
Katari SR, Magnone M, Shapiro R, Jordan M, Scantlebury V, Vivas C, et al. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clin Transpl 1997;11:237-42.
-
(1997)
Clin Transpl
, vol.11
, pp. 237-242
-
-
Katari, S.R.1
Magnone, M.2
Shapiro, R.3
Jordan, M.4
Scantlebury, V.5
Vivas, C.6
-
2
-
-
0026662551
-
Cytochrome P-4503A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat
-
Sattler M, Guengerich FP, Yun C-H, Christians U, Sewing K-F, Cytochrome P-4503A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992;20:753-61.
-
(1992)
Drug Metab Dispos
, vol.20
, pp. 753-761
-
-
Sattler, M.1
Guengerich, F.P.2
Yun, C.-H.3
Christians, U.4
Sewing, K.-F.5
-
3
-
-
0029560982
-
Metabolism of the immunosuppressant tacrolimus in the small intestine: Cytochrome P450, drug interactions, and interindividual variability
-
Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, et al. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos 1995;23:1315-24.
-
(1995)
Drug Metab Dispos
, vol.23
, pp. 1315-1324
-
-
Lampen, A.1
Christians, U.2
Guengerich, F.P.3
Watkins, P.B.4
Kolars, J.C.5
Bader, A.6
-
4
-
-
0027418815
-
Human P-glycoprotein transports cyclosporin A and FK506
-
Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 1993;268: 6077-80.
-
(1993)
J Biol Chem
, vol.268
, pp. 6077-6080
-
-
Saeki, T.1
Ueda, K.2
Tanigawara, Y.3
Hori, R.4
Komano, T.5
-
5
-
-
0025134337
-
Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary culture of human hepatocytes and in liver microsomes
-
Pichard L, Fabre I, Fabre G, Domergue J, Saint-Aubert B, Mourad G, et al. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary culture of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990;18:595-606.
-
(1990)
Drug Metab Dispos
, vol.18
, pp. 595-606
-
-
Pichard, L.1
Fabre, I.2
Fabre, G.3
Domergue, J.4
Saint-Aubert, B.5
Mourad, G.6
-
6
-
-
0027309055
-
P-glycoprotein-mediated transcellular transport of MDR-reversing agents
-
Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. P-glycoprotein-mediated transcellular transport of MDR-reversing agents. FEBS Lett 1993; 324:99-102.
-
(1993)
FEBS Lett
, vol.324
, pp. 99-102
-
-
Saeki, T.1
Ueda, K.2
Tanigawara, Y.3
Hori, R.4
Komano, T.5
-
7
-
-
0028178874
-
Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines
-
Muller C, Bailly JD, Goubin F, Laredo J, Jaffr'ezou JP, Bordier C, et al. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. Int J Cancer 1994;56:749-54.
-
(1994)
Int J Cancer
, vol.56
, pp. 749-754
-
-
Muller, C.1
Bailly, J.D.2
Goubin, F.3
Laredo, J.4
Jaffr'ezou, J.P.5
Bordier, C.6
-
8
-
-
0032472791
-
Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form
-
Rebbeor JF, Senior AE. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form. Biochim Biophys Acta 1998;1369:85-93.
-
(1998)
Biochim Biophys Acta
, vol.1369
, pp. 85-93
-
-
Rebbeor, J.F.1
Senior, A.E.2
-
9
-
-
0027491349
-
Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes
-
Iwasaki K, Matsuda H, Nagase K, Shiraga T, Tokuma Y, Uchida K. Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes. Res Commun Chem Mol Pathol Pharmacol 1993;82:209-16.
-
(1993)
Res Commun Chem Mol Pathol Pharmacol
, vol.82
, pp. 209-216
-
-
Iwasaki, K.1
Matsuda, H.2
Nagase, K.3
Shiraga, T.4
Tokuma, Y.5
Uchida, K.6
-
10
-
-
0029917794
-
Interaction between FK 506 and diltiazem in an animal model
-
Regazzi MB, Iacona I, Alessiani M, Spada M, Vaccarisi S, Villani P, et al. Interaction between FK 506 and diltiazem in an animal model. Transplant Proc 1996;28:1017-8.
-
(1996)
Transplant Proc
, vol.28
, pp. 1017-1018
-
-
Regazzi, M.B.1
Iacona, I.2
Alessiani, M.3
Spada, M.4
Vaccarisi, S.5
Villani, P.6
-
12
-
-
0029012986
-
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients
-
Furlan V, Perello L, Jacquemin E, Debray D, Taburet A-M. Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. Transplantation 1995;59:1217-8.
-
(1995)
Transplantation
, vol.59
, pp. 1217-1218
-
-
Furlan, V.1
Perello, L.2
Jacquemin, E.3
Debray, D.4
Taburet, A.-M.5
-
13
-
-
0028361593
-
Inhibition of human CYP3A catalyzed l′-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine
-
Wrighton SA, Ring BJ. Inhibition of human CYP3A catalyzed l′-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharm Res 1994;11:921-4.
-
(1994)
Pharm Res
, vol.11
, pp. 921-924
-
-
Wrighton, S.A.1
Ring, B.J.2
-
14
-
-
0029148281
-
In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys
-
Gant TW, O'Connor CK, Corbitt R, Thorgeirsson U, Thorgeirsson SS. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol Appl Pharmacol 1995;133:269-76.
-
(1995)
Toxicol Appl Pharmacol
, vol.133
, pp. 269-276
-
-
Gant, T.W.1
O'Connor, C.K.2
Corbitt, R.3
Thorgeirsson, U.4
Thorgeirsson, S.S.5
-
15
-
-
0027404117
-
Protective effects of calcium antagonists in different organs and tissues
-
van Zwieten PA. Protective effects of calcium antagonists in different organs and tissues. Am Heart J 1993;125:566-71.
-
(1993)
Am Heart J
, vol.125
, pp. 566-571
-
-
Van Zwieten, P.A.1
|